University College London/University of Gothenburg PhD course “Biomarkers in neurodegenerative diseases” 2019—course organisation
Abstract Biomarkers are increasingly employed for effective research into neurodegenerative diseases. They have become essential for reaching an accurate clinical diagnosis, monitoring disease, and refining entry criteria for participation in clinical treatment trials, and will be key in measuring t...
Main Authors: | Ayesha Khatun, Ross W. Paterson, Michael Schöll |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | Alzheimer’s Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13195-020-0583-z |
Similar Items
-
Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg
by: Pawel Obrocki, et al.
Published: (2020-02-01) -
Relevance of biomarkers across different neurodegenerative
by: Alexander J. Ehrenberg, et al.
Published: (2020-05-01) -
Targeting amyloid proteins for clinical diagnosis of neurodegenerative diseases
by: Shenqing Zhang, et al.
Published: (2023-07-01) -
Recent High-Resolution Structures of Amyloids Involved in Neurodegenerative Diseases
by: Rodrigo Diaz-Espinoza
Published: (2021-11-01) -
From clinical phenotype to proteinopathy: molecular neuroimaging in neurodegenerative dementias
by: Adalberto Studart-Neto, et al.
Published: (2022-08-01)